论文部分内容阅读
近年国内报道三磷酸腺苷(ATP)转复阵发性室上性心动过速(PSVT)的有效率达88.8～93.3%。方法简便,作用迅速,适于推广应用,但对其副作用未引起重视。本文总结我院近三年转复64例次的临床体会,并就其安全性加以讨论。临床资料一、病例选择:共56例64例次。男34例,女22例,平均年龄35.7+13.1岁。病因:冠心病4例,高血压病5例,心肌病2例,无器质性心脏病证据45例。PSVT 机制:64例次中,预激综合征23例次,食管心房调搏测定为交
In recent years, domestic reports of adenosine triphosphate (ATP) conversion paroxysmal supraventricular tachycardia (PSVT) effective rate of 88.8 ~ 93.3%. The method is simple, rapid, suitable for the promotion of application, but its side effects did not pay attention. This article summarizes the clinical experience of 64 cases in our hospital in the past three years and discusses its safety. Clinical data A case selection: a total of 56 cases of 56 cases. There were 34 males and 22 females, with an average age of 35.7 + 13.1 years. Etiology: 4 cases of coronary heart disease, 5 cases of hypertension, cardiomyopathy in 2 cases, no evidence of organic heart disease in 45 cases. PSVT mechanism: 64 cases, the pre-excitation syndrome in 23 cases, esophageal atrial pacing was determined to pay